On-Demand Webinar: Current Management of AMD
Description
Knowledge regarding best practices for both dry and wet AMD continues to evolve with new, major clinical trial results such as AREDS2 and additional follow-up and analyses from CATT, IVAN, HARBOR, and others. Synthesizing all this new data is key to managing patients with all stages of AMD.
Faculty/Topics
Three world-renowned speakers utilize a case-based format to present approximately 5 wet- and dry-AMD treatment scenarios.
Carl D. Regillo, MD, FACS
Wills Eye Institute
Philadelphia, PA
David M. Brown, MD
Retina Consultants of Houston
Houston, TX
David S. Boyer, MD
Retina-Vitreous Associates Medical Group
Los Angeles, CA
Course Objectives
After viewing this webinar, you will be able to:
- Interpret and apply the new AREDS2 clinical trial results to best manage patients with dry AMD
- Assess the pros and cons of various wet AMD treatment regimens in order to formulate the best treatment plans for patients
- Apply new information from wet AMD studies to maximize safety and efficacy of anti-VEGF therapy
Physician Competencies: Patient Care, Medical Knowledge
Estimated Completion Time: 1.0 hour
Format: internet based enduring material
Method of Participation: review webinar and complete on-line post-test
Eligibility for CME credit: passing score of 80% (unlimited attempts)
Continuing Medical Education Credits
The American Society of Retina Specialists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Retina Specialists designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You will receive a confirmation email with a link to access the webinar as well as instructions to complete CME. This activity will be available until December 31, 2014.
Registration
Regular rate
$30.00